The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness
| Autor: | J. D. A. Whitelaw, R. A. Sandison, A. M. Spencer |
|---|---|
| Rok vydání: | 1954 |
| Předmět: |
Drug
Ergot Alkaloids medicine.medical_specialty Psychotherapist medicine.medical_treatment media_common.quotation_subject 050108 psychoanalysis 050105 experimental psychology chemistry.chemical_compound Electroconvulsive therapy medicine 0501 psychology and cognitive sciences Electroconvulsive Therapy Psychiatry Lysergic acid diethylamide media_common Mental Disorders 05 social sciences General Medicine Mental illness medicine.disease Psychosurgery Psychotherapy Lysergic acid Clear consciousness Lysergic Acid Diethylamide chemistry Ergonovine Psychology medicine.drug |
| Zdroj: | Journal of Mental Science. 100:491-507 |
| ISSN: | 2514-9946 0368-315X |
| DOI: | 10.1192/bjp.100.419.491 |
| Popis: | D-lysergic acid diethylamide (LSD 25) was first prepared in 1938 by Stoll and Hofmann. It is the synthetic amide of d-lysergic acid with a secondary amine, diethylamine and belongs to the ergonovine group of ergot alkaloids all of which have lysergic acid as a base. After its ingestion in minute doses, it induces psychic states in which the subject becomes aware of repressed memories and other unconscious material in a setting of clear consciousness. This preliminary paper describes the results obtained from the use of the drug in 36 psychoneurotic patients over a period of one year. We consider that the drug will find a significant place in the treatment of the psychoneuroses and allied mental illnesses. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|